Zhejiang Cheng Yi Pharmaceutical Co., Ltd.

Form 483 issued November 22, 2019 · Wenzhou City, China

Inspection
Nov 18 – Nov 22, 2019
Investigator
Santos E. Camara
Observations
4
Pages
3
FEI number
3004090742

In short: On November 22, 2019, FDA issued a Form 483 with 4 observations to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. in Wenzhou City, Zhejiang (FEI 3004090742) after an inspection that ran Nov 18 – Nov 22, 2019. The investigator was Santos E. Camara. Most observations concern production and quality system.

At a glance

Production and quality system account for 3 of 4 observations.

Production2
Quality system1
Materials1

What FDA observed

Preview: the opening words of each observation
  1. 01

    The quality control unit lacks authority to review production records to assure that no errors have…

  2. 02

    Written procedures are not drafted, reviewed and approved by the appropriate organizational units and reviewed and…

  3. 03

    Control procedures are not established which validate the performance of those manufacturing processes that may be…

  4. 04

    Drug products are not stored under appropriate conditions of temperature so that their identity, strength, quality…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Zhejiang Cheng Yi Pharmaceutical Co., Ltd.?

FDA listed 4 observations on this Form 483, mostly about production, quality system and materials. The opening words of each observation are shown on this page.

Who inspected Zhejiang Cheng Yi Pharmaceutical Co., Ltd.?

Santos E. Camara is named on this Form 483, for the inspection of Nov 18 – Nov 22, 2019. Each investigator has a profile showing what they cite most.

When was Zhejiang Cheng Yi Pharmaceutical Co., Ltd. inspected by FDA?

The inspection ran Nov 18 – Nov 22, 2019, and the Form 483 is dated November 22, 2019.

How do I get the full Form 483 for Zhejiang Cheng Yi Pharmaceutical Co., Ltd.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free